Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neuroendocrine Tumors × Ondansetron × 30 days × Clear all

Sponsor

Conditions

Vulvar Neoplasms 1 Vulvar Diseases 1 Uterine Cervical Dysplasia 1 Papillomavirus Infections 1 Carcinoma, Hepatocellular 1 Carcinoma in Situ 1

Interventions

Specimen Handling 5 Magnetic Resonance Spectroscopy 5 pembrolizumab 3 Everolimus 3 lutetium Lu 177 dotatate 2 lenvatinib 2 cabozantinib 2 X-Rays 2 Phantoms, Imaging 2 Nivolumab 2 Ipilimumab 2 Etoposide 2 Cyclophosphamide 2 Cisplatin 2 peposertib 1 pazopanib 1 gallium Ga 68 dotatate 1 fludarabine phosphate 1 fludarabine 1 entrectinib 1 entinostat 1 belinostat 1 aldesleukin 1 Salts 1 Radiotherapy 1 Radionuclide Imaging 1 Radiation 1 Positron-Emission Tomography 1 Platinum 1 Octreotide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡